These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26082756)

  • 21. Neutrophil-activating protein (HP-NAP) versus ferritin (Pfr): comparison of synthesis in Helicobacter pylori.
    Dundon WG; Polenghi A; Del Guidice G; Rappuoli R; Montecucco C
    FEMS Microbiol Lett; 2001 May; 199(1):143-9. PubMed ID: 11356582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor.
    Satin B; Del Giudice G; Della Bianca V; Dusi S; Laudanna C; Tonello F; Kelleher D; Rappuoli R; Montecucco C; Rossi F
    J Exp Med; 2000 May; 191(9):1467-76. PubMed ID: 10790422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori and Extragastric Diseases.
    Kyburz A; Müller A
    Curr Top Microbiol Immunol; 2017; 400():325-347. PubMed ID: 28124160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori seropositivity protects against childhood asthma and inversely correlates to its clinical and functional severity.
    Fouda EM; Kamel TB; Nabih ES; Abdelazem AA
    Allergol Immunopathol (Madr); 2018; 46(1):76-81. PubMed ID: 28645881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The recombinant fusion protein of cholera toxin B and neutrophil-activating protein expressed on Bacillus subtilis spore surface suppresses allergic inflammation in mice.
    Dong H; Huang Y; Yao S; Liang B; Long Y; Xie Y; Mai J; Gong S; Zhou Z
    Appl Microbiol Biotechnol; 2017 Jul; 101(14):5819-5829. PubMed ID: 28608279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inflammation, immunity, and vaccines for Helicobacter pylori.
    D'Elios MM; Andersen LP
    Helicobacter; 2009 Sep; 14 Suppl 1():21-8. PubMed ID: 19712164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent.
    D'Elios MM; Amedei A; Cappon A; Del Prete G; de Bernard M
    FEMS Immunol Med Microbiol; 2007 Jul; 50(2):157-64. PubMed ID: 17521355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The neutrophil-activating protein of Helicobacter pylori promotes Th1 immune responses.
    Amedei A; Cappon A; Codolo G; Cabrelle A; Polenghi A; Benagiano M; Tasca E; Azzurri A; D'Elios MM; Del Prete G; de Bernard M
    J Clin Invest; 2006 Apr; 116(4):1092-101. PubMed ID: 16543949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of Helicobacter pylori infection in the development of allergic asthma.
    Taube C; Müller A
    Expert Rev Respir Med; 2012 Aug; 6(4):441-9. PubMed ID: 22971068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inverse associations of Helicobacter pylori with asthma and allergy.
    Chen Y; Blaser MJ
    Arch Intern Med; 2007 Apr; 167(8):821-7. PubMed ID: 17452546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phillygenin Inhibits
    Li RJ; Qin C; Huang GR; Liao LJ; Mo XQ; Huang YQ
    Front Microbiol; 2022; 13():863624. PubMed ID: 35572695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of DEAE negative mode chromatography and gel-filtration chromatography on the charge status of Helicobacter pylori neutrophil-activating protein.
    Hong ZW; Yang YC; Pan T; Tzeng HF; Fu HW
    PLoS One; 2017; 12(3):e0173632. PubMed ID: 28328957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori Resists the Antimicrobial Activity of Calprotectin via Lipid A Modification and Associated Biofilm Formation.
    Gaddy JA; Radin JN; Cullen TW; Chazin WJ; Skaar EP; Trent MS; Algood HM
    mBio; 2015 Dec; 6(6):e01349-15. PubMed ID: 26646009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Helicobacter urease-induced activation of the TLR2/NLRP3/IL-18 axis protects against asthma.
    Koch KN; Hartung ML; Urban S; Kyburz A; Bahlmann AS; Lind J; Backert S; Taube C; Müller A
    J Clin Invest; 2015 Aug; 125(8):3297-302. PubMed ID: 26214524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced risk of atopic disorders in adults with Helicobacter pylori infection.
    McCune A; Lane A; Murray L; Harvey I; Nair P; Donovan J; Harvey R
    Eur J Gastroenterol Hepatol; 2003 Jun; 15(6):637-40. PubMed ID: 12840675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of mastic gum Pistacia lentiscus var. Chia on innate cellular immune effectors.
    Kottakis F; Kouzi-Koliakou K; Pendas S; Kountouras J; Choli-Papadopoulou T
    Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):143-9. PubMed ID: 19212203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The controversy over anti-Helicobacter pylori therapy.
    Bocian KM; Jagusztyn-Krynicka EK
    Pol J Microbiol; 2012; 61(4):239-46. PubMed ID: 23484406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vector-encoded Helicobacter pylori neutrophil-activating protein promotes maturation of dendritic cells with Th1 polarization and improved migration.
    Ramachandran M; Jin C; Yu D; Eriksson F; Essand M
    J Immunol; 2014 Sep; 193(5):2287-96. PubMed ID: 25049358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fusion expression of Helicobacter pylori neutrophil-activating protein in E.coli.
    Kang QZ; Duan GC; Fan QT; Xi YL
    World J Gastroenterol; 2005 Jan; 11(3):454-6. PubMed ID: 15637768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inverse association between Helicobacter pylori and pediatric asthma in a high-prevalence population.
    Zevit N; Balicer RD; Cohen HA; Karsh D; Niv Y; Shamir R
    Helicobacter; 2012 Feb; 17(1):30-5. PubMed ID: 22221613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.